The Clinical Practice Guidelines (CPG) propose recommendations for the diagnosis,
treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the …

Non-alcoholic fatty liver disease (NAFLD) is very common in people with type 2 diabetes
and although estimates for the prevalence NAFLD vary according to age, obesity and …

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …

The current epidemic of non-alcoholic fatty liver disease (NAFLD) is reshaping the field of
hepatology all around the world. The widespread diffusion of metabolic risk factors such as …

Aims/hypothesis We aimed to assess the application of the recent European Association for
the Study of the Liver (EASL)–European Association for the Study of Diabetes (EASD) …

Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …

Nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults,
paralleling the epidemic of obesity and diabetes, and leading to worrisome events …

This review of the literature consists of three sections. First, papers concerning non-alcoholic
fatty liver disease (NAFLD) awareness among the general population, general practitioners …

Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide.
NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
increasingly relevant public health issues owing to their close association with the …